Subscribe to RSS
DOI: 10.1055/s-0032-1326963
Occupational Asthma
Publication History
Publication Date:
09 October 2012 (online)
Abstract
Population-based studies suggest that one in 10 cases of new, recurrent, or deteriorating asthma in adulthood is related to the workplace environment. Nonspecific, irritant exposures at work can upset symptom control in pre-existing disease (work-exacerbated asthma); where disease arises de novo from the workplace (occupational asthma) it generally has an allergic basis, arising from airborne exposure to a sensitizing agent. Over 350 workplace substances have been identified as asthmagens; most are either proteins or highly reactive chemicals. The diagnosis of occupational asthma should be rapid but precise because definitive identification of the causative exposure provides the greatest opportunity for appropriate workplace adaptations and functional improvement. The majority of cases can be diagnosed through a combination of a careful history, appropriate immunology (where available), and the detection of work-related variability in measurements of lung function made serially at work and at home. Occupational asthma is a disease that is potentially preventable and often curable; positive outcomes are dependent more on changes in the workplace than on pharmacological therapy.
-
References
- 1 Torén K, Blanc PD. Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fraction. BMC Pulm Med 2009; 9: 7
- 2 de Bono J, Hudsmith L. Occupational asthma: a community based study. Occup Med (Lond) 1999; 49 (4) 217-219
- 3 Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS): persistent asthma syndrome after high level irritant exposures. Chest 1985; 88 (3) 376-384
- 4 Zock JP, Plana E, Jarvis D , et al. The use of household cleaning sprays and adult asthma: an international longitudinal study. Am J Respir Crit Care Med 2007; 176 (8) 735-741
- 5 Ayres JG, Boyd R, Cowie H, Hurley JF. Costs of occupational asthma in the UK. Thorax 2011; 66 (2) 128-133
- 6 European Academy of Allergy and Clinical Immunology. Allergen List 2010. 2010. http://www.eaaci.net/sections-a-igs/ig-on-occupational-allergy/allergen-list . Accessed September 12, 2012
- 7 Asthme professionnel 2011. http://www.asthme.csst.qc.ca/info_med/index.html . Accessed September 12, 2012
- 8 Malo J-L, Chan-Yeung M. Agents causing occupational asthma with key references. In: Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein D, , eds. Asthma in the Workplace. 3rd ed. London:: Taylor and Francis;; 2006: 852-866
- 9 Manchester asthma hazard programme. 2011 http://www.medicine.manchester.ac.uk/oeh/research/workrelatedillhealth/asthma/ . Accessed August 24, 2011
- 10 Seed M, Agius R. Further validation of computer-based prediction of chemical asthma hazard. Occup Med (Lond) 2010; 60 (2) 115-120
- 11 Draper A, Newman Taylor A, Cullinan P. Estimating the incidence of occupational asthma and rhinitis from laboratory animal allergens in the UK, 1999–2000. Occup Environ Med 2003; 60 (8) 604-605
- 12 Balmes J, Becklake M, Blanc P , et al; Environmental and Occupational Health Assembly, American Thoracic Society. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003; 167 (5) 787-797
- 13 Kogevinas M, Zock JP, Jarvis D , et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007; 370 (9584) 336-341
- 14 Kogevinas M, Antó JM, Sunyer J, Tobias A, Kromhout H, Burney P ; European Community Respiratory Health Survey Study Group. Occupational asthma in Europe and other industrialised areas: a population-based study. Lancet 1999; 353 (9166) 1750-1754
- 15 Jaakkola JJ, Piipari R, Jaakkola MS. Occupation and asthma: a population-based incident case-control study. Am J Epidemiol 2003; 158 (10) 981-987
- 16 Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocyanates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 1998; 101 (5) 709-715
- 17 Jones MG, Floyd A, Nouri-Aria KT , et al. Is occupational asthma to diisocyanates a non-IgE-mediated disease?. J Allergy Clin Immunol 2006; 117 (3) 663-669
- 18 Malo J-L, Bernstein I. Other chemical substances causing occupational asthma. In: Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein D, , eds. Asthma in the Workplace. New York: Marcel Dekker; 1992: 481-582
- 19 Tse KS, Chan H, Chan-Yeung M. Specific IgE antibodies in workers with occupational asthma due to western red cedar. Clin Allergy 1982; 12 (3) 249-258
- 20 Maestrelli P, Del Prete GF, De Carli M , et al. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health 1994; 20 (5) 376-381
- 21 Wisnewski AV, Herrick CA, Liu Q, Chen L, Bottomly K, Redlich CA. Human gamma/delta T-cell proliferation and IFN-gamma production induced by hexamethylene diisocyanate. J Allergy Clin Immunol 2003; 112 (3) 538-546
- 22 Chan-Yeung M, Lam S, Koener S. Clinical features and natural history of occupational asthma due to western red cedar (Thuja plicata). Am J Med 1982; 72 (3) 411-415
- 23 Davies RJ, Butcher BT, O'Neil CE, Salvaggio JE. The in vitro effect of toluene diisocyanate on lymphocyte cyclic adenosine monophosphate production by isoproterenol, prostaglandin, and histamine: a possible mode of action. J Allergy Clin Immunol 1977; 60 (4) 223-229
- 24 McKay RT, Brooks SM, Johnson C. Isocyanate-induced abnormality of beta-adrenergic receptor function. Chest 1981; 80 (1, Suppl) 61-63
- 25 Sheppard D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson DB. Toluene diisocyanate increases airway responsiveness to substance P and decreases airway neutral endopeptidase. J Clin Invest 1988; 81 (4) 1111-1115
- 26 Mapp CE, Chitano P, Fabbri LM , et al. Evidence that toluene diisocyanate activates the efferent function of capsaicin-sensitive primary afferents. Eur J Pharmacol 1990; 180 (1) 113-118
- 27 Lemière C, Malo JL, Boutet M. Reactive airways dysfunction syndrome due to chlorine: sequential bronchial biopsies and functional assessment. Eur Respir J 1997; 10 (1) 241-244
- 28 Lemière C, Malo JL, Boulet LP, Boutet M. Reactive airways dysfunction syndrome induced by exposure to a mixture containing isocyanate: functional and histopathologic behaviour. Allergy 1996; 51 (4) 262-265
- 29 Bardana Jr EJ. Reactive airways dysfunction syndrome (RADS): guidelines for diagnosis and treatment and insight into likely prognosis. Ann Allergy Asthma Immunol 1999; 83 (6 Pt 2) 583-586
- 30 Newman Taylor AJ, Cullinan P, Lympany PA, Harris JM, Dowdeswell RJ, du Bois RM. Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am J Respir Crit Care Med 1999; 160 (2) 435-438
- 31 Cullinan P, Harris JM, Newman Taylor AJ , et al. An outbreak of asthma in a modern detergent factory. Lancet 2000; 356 (9245) 1899-1900
- 32 Cathcart M, Nicholson P, Roberts D , et al; Medical Subcommittee of the UK Soap and Detergent Industry Association. Enzyme exposure, smoking and lung function in employees in the detergent industry over 20 years. Occup Med (Lond) 1997; 47 (8) 473-478
- 33 Juniper CP, How MJ, Goodwin BF, Kinshott AK. Bacillus subtilis enzymes: a 7-year clinical, epidemiological and immunological study of an industrial allergen. J Soc Occup Med 1977; 27 (1) 3-12
- 34 Liss GM, Bernstein D, Genesove L, Roos JO, Lim J. Assessment of risk factors for IgE-mediated sensitization to tetrachlorophthalic anhydride. J Allergy Clin Immunol 1993; 92 (2) 237-247
- 35 Brisman J, Järvholm B, Lillienberg L. Exposure-response relations for self reported asthma and rhinitis in bakers. Occup Environ Med 2000; 57 (5) 335-340
- 36 Cullinan P, Lowson D, Nieuwenhuijsen MJ , et al. Work related symptoms, sensitisation, and estimated exposure in workers not previously exposed to flour. Occup Environ Med 1994; 51 (9) 579-583
- 37 Cullinan P, Cook A, Nieuwenhuijsen MJ , et al. Allergen and dust exposure as determinants of work-related symptoms and sensitization in a cohort of flour-exposed workers; a case-control analysis. Ann Occup Hyg 2001; 45 (2) 97-103
- 38 Heederik D, Houba R. An exploratory quantitative risk assessment for high molecular weight sensitizers: wheat flour. Ann Occup Hyg 2001; 45 (3) 175-185
- 39 Houba R, Heederik DJ, Doekes G, van Run PE. Exposure-sensitization relationship for alpha-amylase allergens in the baking industry. Am J Respir Crit Care Med 1996; 154 (1) 130-136
- 40 Houba R, Heederik D, Doekes G. Wheat sensitization and work-related symptoms in the baking industry are preventable. An epidemiologic study. Am J Respir Crit Care Med 1998; 158 (5 Pt 1) 1499-1503
- 41 Musk AW, Venables KM, Crook B , et al. Respiratory symptoms, lung function, and sensitisation to flour in a British bakery. Br J Ind Med 1989; 46 (9) 636-642
- 42 Nieuwenhuijsen MJ, Heederik D, Doekes G, Venables KM, Newman Taylor AJ. Exposure-response relations of alpha-amylase sensitisation in British bakeries and flour mills. Occup Environ Med 1999; 56 (3) 197-201
- 43 Vanhanen M, Tuomi T, Nordman H , et al. Sensitization to industrial enzymes in enzyme research and production. Scand J Work Environ Health 1997; 23 (5) 385-391
- 44 Weill H, Waddell LC, Ziskind M. A study of workers exposed to detergent enzymes. JAMA 1971; 217 (4) 425-433
- 45 Cullinan P, Cook A, Gordon S , et al. Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J 1999; 13 (5) 1139-1143
- 46 Heederik D, Venables KM, Malmberg P , et al. Exposure-response relationships for work-related sensitization in workers exposed to rat urinary allergens: results from a pooled study. J Allergy Clin Immunol 1999; 103 (4) 678-684
- 47 Kruize H, Post W, Heederik D, Martens B, Hollander A, van der Beek E. Respiratory allergy in laboratory animal workers: a retrospective cohort study using pre-employment screening data. Occup Environ Med 1997; 54 (11) 830-835
- 48 Platts-Mills TA, Longbottom J, Edwards J, Cockroft A, Wilkins S. Occupational asthma and rhinitis related to laboratory rats: serum IgG and IgE antibodies to the rat urinary allergen. J Allergy Clin Immunol 1987; 79 (3) 505-515
- 49 McSharry C, Anderson K, McKay IC , et al. The IgE and IgG antibody responses to aerosols of Nephrops norvegicus (prawn) antigens: the association with clinical hypersensitivity and with cigarette smoking. Clin Exp Immunol 1994; 97 (3) 499-504
- 50 Ortega HG, Daroowalla F, Petsonk EL , et al. Respiratory symptoms among crab processing workers in Alaska: epidemiological and environmental assessment. Am J Ind Med 2001; 39 (6) 598-607
- 51 Osterman K, Zetterström O, Johansson SG. Coffee worker's allergy. Allergy 1982; 37 (5) 313-322
- 52 Meredith SK, Bugler J, Clark RL. Isocyanate exposure and occupational asthma: a case-referent study. Occup Environ Med 2000; 57 (12) 830-836
- 53 Petsonk EL, Wang ML, Lewis DM, Siegel PD, Husberg BJ. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 2000; 118 (4) 1183-1193
- 54 Pronk A, Preller L, Raulf-Heimsoth M , et al. Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am J Respir Crit Care Med 2007; 176 (11) 1090-1097
- 55 Tarlo SM, Liss GM, Dias C, Banks DE. Assessment of the relationship between isocyanate exposure levels and occupational asthma. Am J Ind Med 1997; 32 (5) 517-521
- 56 Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman Taylor AJ. Risk factors for sensitisation and respiratory symptoms among workers exposed to acid anhydrides: a cohort study. Occup Environ Med 1998; 55 (10) 684-691
- 57 Grammer LC, Shaughnessy MA, Lowenthal M, Yarnold PR. Risk factors for immunologically mediated respiratory disease from hexahydrophthalic anhydride. J Occup Med 1994; 36 (6) 642-646
- 58 Burge PS, Edge G, Hawkins R, White V, Taylor AJ. Occupational asthma in a factory making flux-cored solder containing colophony. Thorax 1981; 36 (11) 828-834
- 59 Coutts IL, Lozewicz S, Dally MB , et al. Respiratory symptoms related to work in a factory manufacturing cimetidine tablets. Br Med J (Clin Res Ed) 1984; 288 (6428) 1418
- 60 Hagmar L, Bellander T, Ranstam J, Skerfving S. Piperazine-induced airway symptoms: exposure-response relationships and selection in an occupational setting. Am J Ind Med 1984; 6 (5) 347-357
- 61 Calverley AE, Rees D, Dowdeswell RJ, Linnett PJ, Kielkowski D. Platinum salt sensitivity in refinery workers: incidence and effects of smoking and exposure. Occup Environ Med 1995; 52 (10) 661-666
- 62 Brooks SM, Edwards Jr JJ, Apol A, Edwards FH. An epidemiologic study of workers exposed to western red cedar and other wood dusts. Chest 1981; 80 (1, Suppl) 30-32
- 63 Nicholson PJ, Cullinan P, Burge PS, Boyle C. Occupational asthma: prevention, identification and management: systematic review and recommendations. British Occupational Health Research Foundation. 2010. http://www.bohrf.org.uk/downloads/OccupationalAsthmaEvidenceReview-Mar2010.pdf . Accessed 2011
- 64 Jeal H, Draper A, Harris J, Taylor AN, Cullinan P, Jones M. Modified Th2 responses at high-dose exposures to allergen: using an occupational model. Am J Respir Crit Care Med 2006; 174 (1) 21-25
- 65 Kern DG. Outbreak of the reactive airways dysfunction syndrome after a spill of glacial acetic acid. Am Rev Respir Dis 1991; 144 (5) 1058-1064
- 66 Venables KM, Dally MB, Nunn AJ , et al. Smoking and occupational allergy in workers in a platinum refinery. BMJ 1989; 299 (6705) 939-942
- 67 Venables KM, Upton JL, Hawkins ER, Tee RD, Longbottom JL, Newman Taylor AJ. Smoking, atopy, and laboratory animal allergy. Br J Ind Med 1988; 45 (10) 667-671
- 68 Venables KM, Dally MB, Burge PS, Pickering CA, Newman Taylor AJ. Occupational asthma in a steel coating plant. Br J Ind Med 1985; 42 (8) 517-524
- 69 Cartier A, Malo JL, Forest F , et al. Occupational asthma in snow crab-processing workers. J Allergy Clin Immunol 1984; 74 (3 Pt 1) 261-269
- 70 Zetterström O, Osterman K, Machado L, Johansson SG. Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br Med J (Clin Res Ed) 1981; 283 (6301) 1215-1217
- 71 Dille JR, Gibbons HL, Spikes GA. Allergic problems in screwworm fly eradication program personnel. Aerosp Med 1968; 39 (10) 1116-1119
- 72 Young RP, Barker RD, Pile KD, Cookson WO, Taylor AJ. The association of HLA-DR3 with specific IgE to inhaled acid anhydrides. Am J Respir Crit Care Med 1995; 151 (1) 219-221
- 73 Sjöstedt L, Willers S, Orbaek P. Human leukocyte antigens in occupational allergy: a possible protective effect of HLA-B16 in laboratory animal allergy. Am J Ind Med 1996; 30 (4) 415-420
- 74 Jeal H, Draper A, Jones M , et al. HLA associations with occupational sensitization to rat lipocalin allergens: a model for other animal allergies?. J Allergy Clin Immunol 2003; 111 (4) 795-799
- 75 Horne C, Quintana PJ, Keown PA, Dimich-Ward H, Chan-Yeung M. Distribution of DRB1 and DQB1 HLA class II alleles in occupational asthma due to western red cedar. Eur Respir J 2000; 15 (5) 911-914
- 76 Rihs HP, Barbalho-Krölls T, Huber H, Baur X. No evidence for the influence of HLA class II in alleles in isocyanate-induced asthma. Am J Ind Med 1997; 32 (5) 522-527
- 77 Mapp CE, Beghè B, Balboni A , et al. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy 2000; 30 (5) 651-656
- 78 Bignon JS, Aron Y, Ju LY , et al. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med 1994; 149 (1) 71-75
- 79 Balboni A, Baricordi OR, Fabbri LM, Gandini E, Ciaccia A, Mapp CE. Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur Respir J 1996; 9 (2) 207-210
- 80 Wikman H, Piirilä P, Rosenberg C , et al. N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics 2002; 12 (3) 227-233
- 81 Piirilä P, Wikman H, Luukkonen R , et al. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 2001; 11 (5) 437-445
- 82 Mapp CE, Fryer AA, De Marzo N , et al. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol 2002; 109 (5) 867-872
- 83 Tarlo SM, Easty A, Eubanks K , et al. Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J Allergy Clin Immunol 2001; 108 (4) 628-633
- 84 Allmers H, Schmengler J, Skudlik C. Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol 2002; 110 (2) 318-323
- 85 Grammer LC, Harris KE, Yarnold PR. Effect of respiratory protective devices on development of antibody and occupational asthma to an acid anhydride. Chest 2002; 121 (4) 1317-1322
- 86 Fisher R, Saunders WB, Murray SJ, Stave GM. Prevention of laboratory animal allergy. J Occup Environ Med 1998; 40 (7) 609-613
- 87 Botham PA, Davies GE, Teasdale EL. Allergy to laboratory animals: a prospective study of its incidence and of the influence of atopy on its development. Br J Ind Med 1987; 44 (9) 627-632
- 88 Tarlo SM, Liss GM, Yeung KS. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med 2002; 59 (1) 58-62
- 89 Drexler H, Schaller KH, Nielsen J , et al. Efficacy of measures of hygiene in workers sensitised to acid anhydrides and the influence of selection bias on the results. Occup Environ Med 1999; 56 (3) 202-205
- 90 Brant A, Nightingale S, Berriman J , et al. Supermarket baker's asthma: how accurate is routine health surveillance?. Occup Environ Med 2005; 62 (6) 395-399
- 91 Kraw M, Tarlo SM. Isocyanate medical surveillance: respiratory referrals from a foam manufacturing plant over a five-year period. Am J Ind Med 1999; 35 (1) 87-91
- 92 Bernstein DI, Korbee L, Stauder T , et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 1993; 92 (3) 387-396
- 93 Tarlo SM, Balmes J, Balkissoon R , et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008; 134 (3, Suppl) 1S-41S
- 94 Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy 2000; 30 (11) 1519-1534
- 95 Malo JL, Lemière C, Desjardins A, Cartier A. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 1997; 10 (7) 1513-1515
- 96 Wisnewski AV. Developments in laboratory diagnostics for isocyanate asthma. Curr Opin Allergy Clin Immunol 2007; 7 (2) 138-145
- 97 Perrin B, Lagier F, L'Archevêque J , et al. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J 1992; 5 (1) 40-48
- 98 Malo JL, Côté J, Cartier A, Boulet LP, L'Archevêque J, Chan-Yeung M. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma?. Thorax 1993; 48 (12) 1211-1217
- 99 Liss GM, Tarlo SM. Peak expiratory flow rates in possible occupational asthma. Chest 1991; 100 (1) 63-69
- 100 Leroyer C, Perfetti L, Trudeau C, L'Archevĕque J, Chan-Yeung M, Malo JL. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma. Am J Respir Crit Care Med 1998; 158 (3) 827-832
- 101 Côté J, Kennedy S, Chan-Yeung M. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J Allergy Clin Immunol 1990; 85 (3) 592-598
- 102 Bright P, Newton DT, Gannon PF, Pantin CF, Burge PS. OASYS-3: improved analysis of serial peak expiratory flow in suspected occupational asthma. Monaldi Arch Chest Dis 2001; 56 (3) 281-288
- 103 Blainey AD, Ollier S, Cundell D, Smith RE, Davies RJ. Occupational asthma in a hairdressing salon. Thorax 1986; 41 (1) 42-50
- 104 Côté J, Kennedy S, Chan-Yeung M. Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Thorax 1993; 48 (1) 48-51
- 105 Gannon PF, Newton DT, Belcher J, Pantin CF, Burge PS. Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax 1996; 51 (5) 484-489
- 106 Venables KM, Davison AG, Browne K, Newman Taylor AJ. Pseudo-occupational asthma. Thorax 1989; 44 (9) 760-761
- 107 Tarlo SM, Broder I. Outcome of assessments for occupational asthma. Chest 1991; 100 (2) 329-335
- 108 Burge PS. Occupational asthma in electronics workers caused by colophony fumes: follow-up of affected workers. Thorax 1982; 37 (5) 348-353
- 109 Bardy JD, Malo JL, Séguin P , et al. Occupational asthma and IgE sensitization in a pharmaceutical company processing psyllium. Am Rev Respir Dis 1987; 135 (5) 1033-1038
- 110 Pickering CA. Inhalation tests with chemical allergens: complex salts of platinum. Proc R Soc Med 1972; 65 (3) 272-274
- 111 Stenton SC, Beach JR, Dennis JH, Keaney NP, Hendrick DJ. Glutaraldehyde, asthma and work—a cautionary tale. Occup Med (Lond) 1994; 44 (2) 95-98
- 112 Cloutier Y, Lagier F, Lemieux R , et al. New methodology for specific inhalation challenges with occupational agents in powder form. Eur Respir J 1989; 2 (8) 769-777
- 113 Carroll KB, Secombe CJ, Pepys J. Asthma due to non-occupational exposure to toluene (tolylene) di-isocyanate. Clin Allergy 1976; 6 (2) 99-104
- 114 Moscato G, Pignatti P, Yacoub MR, Romano C, Spezia S, Perfetti L. Occupational asthma and occupational rhinitis in hairdressers. Chest 2005; 128 (5) 3590-3598
- 115 Obata H, Dittrick M, Chan H, Chan-Yeung M. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur Respir J 1999; 13 (3) 489-495
- 116 Lemière C, Chaboillez S, Malo JL, Cartier A. Changes in sputum cell counts after exposure to occupational agents: what do they mean?. J Allergy Clin Immunol 2001; 107 (6) 1063-1068
- 117 Lemière C, Chaboilliez S, Trudeau C , et al. Characterization of airway inflammation after repeated exposures to occupational agents. J Allergy Clin Immunol 2000; 106 (6) 1163-1170
- 118 Yacoub MR, Lavoie K, Lacoste G , et al. Assessment of impairment/disability due to occupational asthma through a multidimensional approach. Eur Respir J 2007; 29 (5) 889-896
- 119 Girard F, Chaboillez S, Cartier A , et al. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med 2004; 170 (8) 845-850
- 120 Barbinova L, Baur X. Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure. Int Arch Occup Environ Health 2006; 79 (5) 387-395
- 121 Baur X, Barbinova L. Increase of exhaled nitric oxide (eNO) after methylene diphenyl diisocyanate (MDI) exposure in isocyanate workers with bronchial hyperresponsiveness. Allergol Int 2005; 54: 151-158
- 122 Baur X, Barbinova L. Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers. Eur Respir J 2005; 25 (2) 309-316
- 123 Piipari R, Piirilä P, Keskinen H, Tuppurainen M, Sovijärvi A, Nordman H. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Respir J 2002; 20 (6) 1532-1537
- 124 Taivainen AI, Tukiainen HO, Terho EO, Husman KR. Powered dust respirator helmets in the prevention of occupational asthma among farmers. Scand J Work Environ Health 1998; 24 (6) 503-507
- 125 Slovak AJ, Orr RG, Teasdale EL. Efficacy of the helmet respirator in occupational asthma due to laboratory animal allergy (LAA). Am Ind Hyg Assoc J 1985; 46 (8) 411-415
- 126 Pisati G, Baruffini A, Zedda S. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br J Ind Med 1993; 50 (1) 60-64
- 127 Obase Y, Shimoda T, Mitsuta K, Matsuse H, Kohno S. Two patients with occupational asthma who returned to work with dust respirators. Occup Environ Med 2000; 57 (1) 62-64
- 128 Müller-Wening D, Neuhauss M. Protective effect of respiratory devices in farmers with occupational asthma. Eur Respir J 1998; 12 (3) 569-572
- 129 Laoprasert N, Swanson MC, Jones RT, Schroeder DR, Yunginger JW. Inhalation challenge testing of latex-sensitive health care workers and the effectiveness of laminar flow HEPA-filtered helmets in reducing rhinoconjunctival and asthmatic reactions. J Allergy Clin Immunol 1998; 102 (6 Pt 1) 998-1004
- 130 Malo JL, Cartier A, Côté J , et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med 1996; 153 (3) 953-960
- 131 Rachiotis G, Savani R, Brant A, MacNeill SJ, Newman Taylor A, Cullinan P. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007; 62 (2) 147-152
- 132 Vandenplas O, Dressel H, Wilken D , et al. Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J 2011; 38 (4) 804-811
- 133 de Groene GJ, Pal TM, Beach J , et al. Workplace interventions for treatment of occupational asthma. Cochrane Database Syst Rev 2011; (5) CD006308
- 134 Beach J, Rowe BH, Blitz S , et al. Diagnosis and management of work-related asthma. Evid Rep Technol Assess (Summ) 2005; (129) 1-8
- 135 Malo JL, Cartier A, Ghezzo H, Lafrance M, McCants M, Lehrer SB. Patterns of improvement in spirometry, bronchial hyperresponsiveness, and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing. Am Rev Respir Dis 1988; 138 (4) 807-812
- 136 Saetta M, Maestrelli P, Turato G , et al. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995; 151 (2 Pt 1) 489-494
- 137 Saetta M, Maestrelli P, Di Stefano A , et al. Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis 1992; 145 (1) 169-174
- 138 Paggiaro P, Bacci E, Paoletti P , et al. Bronchoalveolar lavage and morphology of the airways after cessation of exposure in asthmatic subjects sensitized to toluene diisocyanate. Chest 1990; 98 (3) 536-542
- 139 Larbanois A, Jamart J, Delwiche JP, Vandenplas O. Socioeconomic outcome of subjects experiencing asthma symptoms at work. Eur Respir J 2002; 19 (6) 1107-1113
- 140 Axon EJ, Beach JR, Burge PS. A comparison of some of the characteristics of patients with occupational and non-occupational asthma. Occup Med (Lond) 1995; 45 (2) 109-111
- 141 Cannon J, Cullinan P, Newman Taylor A. Consequences of occupational asthma. BMJ 1995; 311 (7005) 602-603
- 142 Ross DJ, McDonald JC. Health and employment after a diagnosis of occupational asthma: a descriptive study. Occup Med (Lond) 1998; 48 (4) 219-225
- 143 Venables KM, Davison AG, Newman Taylor AJ. Consequences of occupational asthma. Respir Med 1989; 83 (5) 437-440
- 144 Poonai N, van Diepen S, Bharatha A, Manduch M, Deklaj T, Tarlo SM. Barriers to diagnosis of occupational asthma in Ontario. Can J Public Health 2005; 96 (3) 230-233
- 145 Fishwick D, Bradshaw L, Davies J , et al. Are we failing workers with symptoms suggestive of occupational asthma?. Prim Care Respir J 2007; 16 (5) 304-310
- 146 Mackie J. Effective health surveillance for occupational asthma in motor vehicle repair. Occup Med (Lond) 2008; 58 (8) 551-555
- 147 Sauni R, Kauppi P, Helaskoski E, Virtema P, Verbeek J. Audit of quality of diagnostic procedures for occupational asthma. Occup Med (Lond) 2009; 59 (4) 230-236